T162. Association of Semantic Priming Deficits With Role Functioning in Persons at Clinical High Risk for Schizophrenia: Evidence From Event-Related Brain Potentials

2019 ◽  
Vol 85 (10) ◽  
pp. S191-S192
Author(s):  
Jenny Lepock ◽  
Romina Mizrahi ◽  
Margaret Maheandiran ◽  
Sarah Ahmed ◽  
Michele Korostil ◽  
...  
2017 ◽  
Vol 81 (10) ◽  
pp. S79
Author(s):  
Jennifer Lepock ◽  
Romina Mizrahi ◽  
Cory Gerritsen ◽  
Lauren Drvaric ◽  
Margaret Maheandiran ◽  
...  

2019 ◽  
Vol 204 ◽  
pp. 434-436 ◽  
Author(s):  
Jennifer R. Lepock ◽  
Romina Mizrahi ◽  
Michele Korostil ◽  
Margaret Maheandiran ◽  
Cory J. Gerritsen ◽  
...  

2018 ◽  
Vol 49 (4) ◽  
pp. 215-225 ◽  
Author(s):  
Jennifer R. Lepock ◽  
Romina Mizrahi ◽  
Michele Korostil ◽  
R. Michael Bagby ◽  
Elizabeth W. Pang ◽  
...  

There is emerging evidence that identification and treatment of individuals in the prodromal or clinical high-risk (CHR) state for psychosis can reduce the probability that they will develop a psychotic disorder. Event-related brain potentials (ERPs) are a noninvasive neurophysiological technique that holds promise for improving our understanding of neurocognitive processes underlying the CHR state. We aimed to systematically review the current literature on cognitive ERP studies of the CHR population, in order to summarize and synthesize the results, and their implications for our understanding of the CHR state. Across studies, amplitudes of the auditory P300 and duration mismatch negativity (MMN) ERPs appear reliably reduced in CHR individuals, suggesting that underlying impairments in detecting changes in auditory stimuli are a sensitive early marker of the psychotic disease process. There are more limited data indicating that an earlier-latency auditory ERP response, the N100, is also reduced in amplitude, and in the degree to which it is modulated by stimulus characteristics, in the CHR population. There is also evidence that a number of auditory ERP measures (including P300, MMN and N100 amplitudes, and N100 gating in response to repeated stimuli) can further refine our ability to detect which CHR individuals are most at risk for developing psychosis. Thus, further research is warranted to optimize the predictive power of algorithms incorporating these measures, which could help efforts to target psychosis prevention interventions toward those most in need.


2019 ◽  
Vol 45 (Supplement_2) ◽  
pp. S337-S337
Author(s):  
Sarah Ahmed ◽  
Jennifer R Lepock ◽  
Margaret Maheandiran ◽  
Tony P George ◽  
Romina Mizrahi ◽  
...  

2017 ◽  
Vol 43 (suppl_1) ◽  
pp. S253-S253
Author(s):  
Ricardo Carrion ◽  
Danielle McLaughlin ◽  
Andrea Auther ◽  
Jean Addington ◽  
Carrie Bearden ◽  
...  

2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S57-S58
Author(s):  
Kate Haining ◽  
Gina Brunner ◽  
Ruchika Gajwani ◽  
Joachim Gross ◽  
Andrew Gumley ◽  
...  

Abstract Background Research in individuals at clinical-high risk for psychosis (CHR-P) has focused on developing algorithms to predict transition to psychosis. However, it is becoming increasingly important to address other outcomes, such as the level of functioning of CHR-P participants. To address this important question, this study investigated the relationship between baseline cognitive performance and functional outcome between 6–12 months in a sample of CHR-P individuals using a machine-learning approach to identify features that are predictive of long-term functional impairments. Methods Data was available for 111 CHR-P individuals at 6–12 months follow-up. In addition, 47 CHR-negative (CHR-N) participants who did not meet CHR criteria and 55 healthy controls (HCs) were recruited. CHR-P status was assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS) and the Schizophrenia Proneness Instrument, Adult version (SPI-A). Cognitive assessments included the Brief Assessment of Cognition in Schizophrenia (BACS) and the Penn Computerized Neurocognitive Battery (CNB). Global, social and role functioning scales were used to measure functional status. CHR-P individuals were divided into good functional outcome (GFO, GAF ≥ 65) and poor functional outcome groups (PFO, GAF < 65). Feature selection was performed using LASSO regression with the LARS algorithm and 10-fold cross validation with GAF scores at baseline as the outcome variable. The following features were identified as predictors of GAF scores at baseline: verbal memory, verbal fluency, attention, emotion recognition, social and role functioning and SPI-A distress. This model explained 47% of the variance in baseline GAF scores. In the next step, Support Vector Machines (SVM), Linear Discriminant Analysis (LDA), Logistic Regression (LR), Gaussian Naïve Bayes (GNB), and Random Forest (RF) classifiers with 10-fold cross validation were then trained on those features with GAF category at follow-up used as the binary label column. Models were compared using a calculated score incorporating area under the curve (AUC), accuracy, and AUC consistency across runs, whereby AUC was given a higher weighting than accuracy due to class imbalance. Results CHR-P individuals had slower motor speed, reduced attention and processing speed and increased emotion recognition reaction times (RTs) compared to HCs and reduced attention and processing speed compared to CHR-Ns. At follow-up, 66% of CHR-P individuals had PFO. LDA emerged as the strongest classifier, showing a mean AUC of 0.75 (SD = 0.15), indicating acceptable classification performance for GAF category at follow-up. PFO was detected with a sensitivity of 75% and specificity of 58%, with a total mean weighted accuracy of 68%. Discussion The CHR-P state was associated with significant impairments in cognition, highlighting the importance of interventions such as cognitive remediation in this population. Our data suggest that the development of features using machine learning approaches is effective in predicting functional outcomes in CHR-P individuals. Greater levels of accuracy, sensitivity and specificity might be achieved by increasing training sets and validating the classifier with external data sets. Indeed, machine learning methods have potential given that trained classifiers can easily be shared online, thus enabling clinical professionals to make individualised predictions.


2017 ◽  
Vol 30 (1) ◽  
pp. 39-47 ◽  
Author(s):  
Eva Velthorst ◽  
Jamie Zinberg ◽  
Jean Addington ◽  
Kristin S. Cadenhead ◽  
Tyrone D. Cannon ◽  
...  

AbstractThe developmental course of daily functioning prior to first psychosis-onset remains poorly understood. This study explored age-related periods of change in social and role functioning. The longitudinal study included youth (aged 12–23, mean follow-up years = 1.19) at clinical high risk (CHR) for psychosis (converters [CHR-C], n = 83; nonconverters [CHR-NC], n = 275) and a healthy control group (n = 164). Mixed-model analyses were performed to determine age-related differences in social and role functioning. We limited our analyses to functioning before psychosis conversion; thus, data of CHR-C participants gathered after psychosis onset were excluded. In controls, social and role functioning improved over time. From at least age 12, functioning in CHR was poorer than in controls, and this lag persisted over time. Between ages 15 and 18, social functioning in CHR-C stagnated and diverged from that of CHR-NC, who continued to improve (p = .001). Subsequently, CHR-C lagged behind in improvement between ages 21 and 23, further distinguishing them from CHR-NC (p < .001). A similar period of stagnation was apparent for role functioning, but to a lesser extent (p = .007). The results remained consistent when we accounted for the time to conversion. Our findings suggest that CHR-C start lagging behind CHR-NC in social and role functioning in adolescence, followed by a period of further stagnation in adulthood.


Author(s):  
Saurabh Somvanshi ◽  
Ragy Girgis ◽  
Gary Brucato ◽  
Lawrence S. Kegeles ◽  
Jared V. Snellenberg ◽  
...  

2012 ◽  
Vol 42 (12) ◽  
pp. 2485-2497 ◽  
Author(s):  
A. M. Auther ◽  
D. McLaughlin ◽  
R. E. Carrión ◽  
P. Nagachandran ◽  
C. U. Correll ◽  
...  

BackgroundClinical and epidemiological studies suggest an association between cannabis use and psychosis but this relationship remains controversial.MethodClinical high-risk (CHR) subjects (age 12–22 years) with attenuated positive symptoms of psychosis (CHR+, n=101) were compared to healthy controls (HC, n=59) on rates of substance use, including cannabis. CHR+ subjects with and without lifetime cannabis use (and abuse) were compared on prodromal symptoms and social/role functioning at baseline. Participants were followed an average of 2.97 years to determine psychosis conversion status and functional outcome.ResultsAt baseline, CHR+ subjects had significantly higher rates of lifetime cannabis use than HC. CHR+ lifetime cannabis users (n=35) were older (p=0.015, trend), more likely to be Caucasian (p=0.002), less socially anhedonic (p<0.001) and had higher Global Functioning: Social (GF:Social) scores (p<0.001) than non-users (n=61). CHR+ cannabis users continued to have higher social functioning than non-users at follow-up (p<0.001) but showed no differences in role functioning. A small sample of CHR+ cannabis abusers (n=10) showed similar results in that abusers were older (p=0.008), less socially anhedonic (p=0.017, trend) and had higher baseline GF:Social scores (p=0.006) than non-abusers. Logistic regression analyses revealed that conversion to psychosis in CHR+ subjects (n=15) was not related to lifetime cannabis use or abuse.ConclusionsThe current data do not indicate that low to moderate lifetime cannabis use is a major contributor to psychosis or poor social and role functioning in clinical high-risk youth with attenuated positive symptoms of psychosis.


Sign in / Sign up

Export Citation Format

Share Document